Acadia Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
19.95
+0.06 (0.30%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Acadia Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 3,437 | 4,519 | 3,053 | 5,140 | 2,578 | 3,752 | |
Market Cap Growth | -4.07% | 48.00% | -40.60% | 99.40% | -31.29% | -55.85% |
Enterprise Value | 2,555 | 3,727 | 2,537 | 4,852 | 2,204 | 3,278 |
Last Close Price | 19.95 | 26.71 | 18.35 | 31.31 | 15.92 | 23.34 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 9.04 | 11.56 | 13.48 | - | - | - |
Forward PE | 25.04 | 40.38 | 35.90 | 27.40 | - | - |
PS Ratio | 3.02 | 4.22 | 3.19 | 7.08 | 4.98 | 7.75 |
PB Ratio | 2.63 | 3.68 | 4.17 | 11.91 | 6.44 | 6.94 |
P/TBV Ratio | 2.86 | 4.04 | 4.98 | 14.04 | 6.44 | 6.94 |
P/FCF Ratio | 23.61 | 42.98 | 19.42 | 308.70 | - | - |
P/OCF Ratio | 21.44 | 41.14 | 19.36 | 307.78 | - | - |
PEG Ratio | - | 7.43 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.24 | 3.48 | 2.65 | 6.68 | 4.26 | 6.77 |
EV/EBITDA Ratio | 25.97 | 31.97 | 25.33 | - | - | - |
EV/EBIT Ratio | 29.58 | 35.56 | 30.11 | - | - | - |
EV/FCF Ratio | 17.54 | 35.44 | 16.14 | 291.36 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.06 | 0.04 | 0.07 | 0.13 | 0.16 | 0.12 |
Debt / EBITDA Ratio | 0.66 | 0.40 | 0.47 | - | - | - |
Debt / FCF Ratio | 0.51 | 0.50 | 0.33 | 3.44 | - | - |
Net Debt / Equity Ratio | -0.68 | -0.62 | -0.96 | -0.88 | -0.89 | -0.84 |
Net Debt / EBITDA Ratio | -8.97 | -6.58 | -7.03 | 5.63 | 1.60 | 2.73 |
Net Debt / FCF Ratio | -6.06 | -7.30 | -4.48 | -22.92 | 3.11 | 3.60 |
Asset Turnover | 0.77 | 0.78 | 0.99 | 1.09 | 0.80 | 0.65 |
Inventory Turnover | 14.77 | 14.76 | 13.33 | 18.53 | 51.22 | 29.44 |
Quick Ratio | 3.11 | 3.49 | 2.18 | 2.13 | 3.82 | 6.10 |
Current Ratio | 3.39 | 3.83 | 2.38 | 2.42 | 4.04 | 6.43 |
Return on Equity (ROE) | 35.74% | 39.89% | 38.89% | -14.73% | -45.89% | -28.75% |
Return on Assets (ROA) | 3.64% | 4.76% | 5.44% | -6.86% | -21.70% | -14.37% |
Return on Invested Capital (ROIC) | 19.82% | 42.90% | 187.48% | -153.38% | -343.44% | -263.80% |
Return on Capital Employed (ROCE) | 6.30% | 8.10% | 10.60% | -14.80% | -48.40% | -28.20% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 11.07% | 8.65% | 7.42% | -1.19% | -8.38% | -4.47% |
FCF Yield | 4.24% | 2.33% | 5.15% | 0.32% | -4.42% | -3.38% |
Buyback Yield / Dilution | -2.98% | -2.14% | -1.55% | -1.32% | -0.74% | -2.01% |